Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 138 participants.

Also called NCT03121430

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 138 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03121430
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03121430. Randomized; single masking; primary purpose treatment. Start 2018-10-22 (actual); primary completion 2020-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion
Condition
Peripheral Arterial Disease
Condition
Superficial Femoral Artery Stenosis
Condition
Superficial Femoral Artery Occlusion
Intervention (Device)
Drug eluting peripheral vascular stent system
Intervention (Device)
Nitinol Stent System
Lead sponsor
Zhejiang Zylox Medical Device Co., Ltd. (class: industry)
Collaborator
Guangzhou Osmunda Medical Device Technology, Inc., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03121430
Content hash
de94115065f2904eb1aa87295f42ce7894dac752c210918d75cace396b429ace